Stoke Therapeutics, Inc. (STOK)
30.16
+0.11
(+0.37%)
USD |
NASDAQ |
Sep 09, 09:57
Stoke Therapeutics Total Liabilities (Quarterly) : 48.42M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.42M |
| March 31, 2026 | 48.40M |
| December 31, 2025 | 65.98M |
| September 30, 2025 | 52.16M |
| June 30, 2025 | 49.56M |
| March 31, 2025 | 56.81M |
| December 31, 2024 | 42.53M |
| September 30, 2024 | 61.21M |
| June 30, 2024 | 65.05M |
| March 31, 2024 | 64.84M |
| December 31, 2023 | 68.78M |
| September 30, 2023 | 66.89M |
| June 30, 2023 | 66.72M |
| March 31, 2023 | 67.97M |
| December 31, 2022 | 71.22M |
| September 30, 2022 | 73.48M |
| Date | Value |
|---|---|
| June 30, 2022 | 77.11M |
| March 31, 2022 | 75.96M |
| December 31, 2021 | 21.09M |
| September 30, 2021 | 16.26M |
| June 30, 2021 | 9.381M |
| March 31, 2021 | 6.443M |
| December 31, 2020 | 11.85M |
| September 30, 2020 | 7.40M |
| June 30, 2020 | 6.814M |
| March 31, 2020 | 6.499M |
| December 31, 2019 | 4.322M |
| September 30, 2019 | 5.144M |
| June 30, 2019 | 4.836M |
| March 31, 2019 | 3.353M |
| December 31, 2018 | 2.471M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 13.24B |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 393.97M |
| Shareholders Equity (Quarterly) | 345.55M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 7.692 |
| Net Debt Paydown Yield | 0.02% |